Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$1.59
CAD
-0.05 (-3.05%)
Last updated: 2026-10-23
Follow CRDL
CRDL
Cardiol Therapeutics Inc Class A
Performance
1 Day
-3.05%
1 Week
+0.63%
1 Month
-36.14%
YTD
+16.91%
Key Statistics
Market Cap
$193.21M
52W High
$3.23
52W Low
$1.23
P/E Ratio
-
50 Day MA
$2.39
200 Day MA
$1.81
Beta
0.72
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/23/2026 | $1.65 | $1.65 | $1.55 | $1.59 | $1.59 | 134,973 |
| 10/22/2026 | $1.66 | $1.67 | $1.61 | $1.64 | $1.64 | 133,566 |
| 10/21/2026 | $1.63 | $1.66 | $1.62 | $1.66 | $1.66 | 143,282 |
| 10/20/2026 | $1.57 | $1.64 | $1.54 | $1.63 | $1.63 | 134,567 |
| 10/19/2026 | $1.57 | $1.58 | $1.53 | $1.57 | $1.57 | 97,738 |
| 10/16/2026 | $1.62 | $1.62 | $1.54 | $1.58 | $1.58 | 143,940 |
| 10/15/2026 | $1.64 | $1.65 | $1.60 | $1.60 | $1.60 | 279,375 |
| 10/14/2026 | $1.70 | $1.70 | $1.60 | $1.60 | $1.60 | 158,320 |
| 10/13/2026 | $1.75 | $1.76 | $1.68 | $1.71 | $1.71 | 217,351 |
| 10/9/2026 | $1.87 | $1.88 | $1.77 | $1.78 | $1.78 | 179,600 |
Analyst Price Targets
Based on analyst covering CRDL · as of Oct 12, 2026
Wall Street analysts forecast CRDL stock price to rise 340.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.00
+340.3% Upside
Previously C$6.00 on Sep 17, 2026
Current Price
C$1.59
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
49.6%
Annualized
90-Day Vol
66.1%
Annualized
Trend (90d)
-28.1%
Annualized drift
90d Mean
C$1.44
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.54 | C$1.30 – C$1.82 |
| 60 trading days | C$1.49 | C$1.17 – C$1.89 |
| 90 trading days | C$1.44 | C$1.07 – C$1.93 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.85M
- Profit Margin
- 0.00%
- ROE (TTM)
- -190.18%
- EPS (Diluted)
- -0.35
- Book Value
- 0.21
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| PNC-A | Postmedia Network Canada Corp | $0.14 | +40.00% |
| EAGR | East Side Games Group Inc | $0.07 | +16.67% |
| CWEB | Charlotte's Web Holdings Inc | $0.36 | +10.61% |
| SNDY | Sunday Lake Gold Corp. | $1.60 | +6.67% |
| GASX | NG Energy International Corp. | $1.01 | +6.32% |
| RVX | Resverlogix Corp. | $0.09 | +5.88% |
| LAM | Laramide Resources Ltd. | $0.46 | +5.81% |
| BNE | Bonterra Energy Corp | $6.82 | +5.74% |
CRDL.TO news timeline
15 articles covering CRDL.TO, most recent first
LatestTop penny stocks on the TSX & TSXV — October 15, 2026
October 2026
- Why Cardiol Therapeutics Inc Class A stock fell yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Why Cardiol Therapeutics Inc Class A stock fell yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Why Cardiol Therapeutics Inc Class A stock is tanking today
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
September 2026
- What's Going On With Cardiol Therapeutics Inc Class A Stock Wednesday?
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Friday?
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Monday?
- Why Cardiol Therapeutics Inc Class A stock surged yesterday